Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples